Pharmacological optimization of tissue perfusion.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19460775.
- Also identified by DOI 10.1093/bja/aep135 and PMC identifier 2700012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After fluid resuscitation, vasoactive drug treatment represents the major cornerstone for correcting any major impairment of the circulation. However, debate still rages as to the choice of agent, dose, timing, targets, and monitoring modalities that should optimally be used to benefit the patient yet, at the same time, minimize harm. This review highlights these areas and some new pharmacological agents that broaden our therapeutic options.
Medical subject headings
- Cardiotonic Agents
- Cardiovascular System
- Vasoconstrictor Agents